ROXY GAZAWAY: Open Payments
NPI 1487279139 · CHATTANOOGA, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,145 in 24 payments from 15 companies in 2025. Trend: 2023 $1,137 · 2024 $455 · 2025 $1,145
Food & beverage: $752Speaker / faculty: $300Education: $93
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 1 | $300 |
| JAZZ PHARMACEUTICALS INC. | 1 | $133 |
| Astellas Pharma US Inc | 2 | $126 |
| Janssen Biotech, Inc. | 2 | $111 |
| SANOFI-AVENTIS U.S. LLC | 1 | $93 |
| Novartis Pharmaceuticals Corporation | 3 | $74 |
| ADC THERAPEUTICS AMERICA, INC. | 3 | $57 |
| Celgene Corporation | 2 | $51 |
| Incyte Corporation | 2 | $51 |
| Gilead Sciences, Inc. | 2 | $43 |
Products named: BLINCYTO, ZIIHERA, Vyloy, RYBREVANT, SARCLISA, ZYNLONTA, REBLOZYL, Trodelvy.
Industry payments across TN — which companies pay providers there.
